Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-037792
Filing Date
2020-08-06
Accepted
2020-08-06 16:26:19
Documents
63
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fprx-10q_20200630.htm   iXBRL 10-Q 2537515
2 EX-10.1 fprx-ex101_13.htm EX-10.1 20586
3 EX-10.2 fprx-ex102_14.htm EX-10.2 9547
4 EX-31.1 fprx-ex311_8.htm EX-31.1 8844
5 EX-31.2 fprx-ex312_7.htm EX-31.2 8494
6 EX-32.1 fprx-ex321_9.htm EX-32.1 5303
7 EX-32.2 fprx-ex322_6.htm EX-32.2 5225
8 GRAPHIC gbv2xluwlx24000001.jpg GRAPHIC 3331
9 GRAPHIC gr4m1lbb1fdr000001.jpg GRAPHIC 3331
10 GRAPHIC ggbtkgjdhydz000001.jpg GRAPHIC 23984
  Complete submission text file 0001564590-20-037792.txt   8588348

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA fprx-20200630.xsd EX-101.SCH 46515
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fprx-20200630_cal.xml EX-101.CAL 46748
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fprx-20200630_def.xml EX-101.DEF 155567
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE fprx-20200630_lab.xml EX-101.LAB 393280
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fprx-20200630_pre.xml EX-101.PRE 289376
16 EXTRACTED XBRL INSTANCE DOCUMENT fprx-10q_20200630_htm.xml XML 1744935
Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS, INC. (Filer) CIK: 0001175505 (see all company filings)

EIN.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36070 | Film No.: 201082109
SIC: 2834 Pharmaceutical Preparations